Kojima M., Hosoda H., Matsuo H., Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol. Metab. 2001, 12: 118–122.
Smith R.G., Van der Ploeg L.H., Howard A.D., et al. Peptidomimetic regulation of growth hormone secretion. Endocr. Rev. 1997, 18: 621–645.
Muccioli G., Tschöp M., Papotti M., et al. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur. J. Pharmacol. 2002, 440: 235–254.
Kojima M., Hosoda H., Kangawa K. Purification and distribution of ghrelin: the natural endogenous ligand for the growth hormone secretagogue receptor. Horm. Res. 2001, 56: 93–97.
Martinez J., Fehrentz J.A., Guerlavais V. Growth hormone secretagogues, PCT — WO 01/96300 A1, 20.12.2001
Muccioli G., Ghe C., Ghigo M.C., et al. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J. Endocrinol. 1998, 157: 99–106.
Muccioli G., Papotti M., Locatelli V., Ghigo E., Deghenghi R. Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. J. Endocrinol. Invest. 2001, 24: RC7–RC9.
Torsello A., Luoni M., Schweiger F., et al. Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release. Eur. J. Pharmacol. 1998, 360: 123–129.
Arvat E., Maccario M., Di Vito L., et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J. Clin. Endocrinol. Metab. 2001, 86: 1169–1174.